Evidence map›Paper›PMID 27819129›Full record

ReviewJournal of Zhejiang University. Science. B

Roles of SIRT3 in heart failure: from bench to bedside.

De-Xing Hu, Xian-Bao Liu, Wen-Chao Song, Jian-An Wang

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of Zhejiang University. Science. B. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Androgen-Regulated Cardiac Metabolism in Aging Men.Frontiers in endocrinology · 2020
    Review
  8. Article
  9. Emerging potential benefits of modulating NADAmerican journal of physiology. Heart and circulatory physiology · 2018
    Review
  10. The Role of Sirtuins in Antioxidant and Redox Signaling.Antioxidants & redox signaling · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

De-Xing HuDepartment of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Xian-Bao LiuDepartment of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Wen-Chao SongDepartment of Cardiology, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo 315100, China.
Jian-An WangDepartment of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Second Affiliated Hospital of Zhejiang University · CNNingbo Medical Center Lihuili Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) represents the most common endpoint of most cardiovascular diseases (CVDs) which are the leading causes of death around the world. Despite the advances in treating CVDs, the prevalence of HF continues to increase. It is believed that better results of prognosis are obtained from prevention rather than additional treatment for HF. Therefore, it is reasonable to prevent the development of CVDs or other complications to HF. Most types of HF are attributed to contractile dysfunction, cardiac hypertrophy or remodeling, and ischemic injuries. SIRT3 is a mitochondrial nicotinamide adenine dinucleotide (NAD

Indexed as

AnimalsCardiomegalyHeart FailureHumansMyocardial Reperfusion InjuryReactive Oxygen SpeciesSirtuin 3Reactive Oxygen SpeciesSIRT3 protein, humanSirtuin 3Heart failureHypertrophyIschemia reperfusionSIRT3

Identifiers

PMID27819129
PMCPMC5120224
OpenAlexW2562121174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.